Jagsonpal Pharmaceuticals Limited

533.5

INR
+1.50(+0.28%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹1383.79 Cr
Enterprise Value
₹1168.54 Cr
P/E Ratio (TTM)
57.90
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
6.10

Financial Metrics

Gross Margin
64.71%
Operating Margin
18.67%
Return on Equity
13.26%
Revenue (TTM)
₹226.85 Cr+29.2%
EBITDA
₹40.66 Cr
EPS (TTM)
₹9.01+53.400000000000006%

Balance Sheet

Total Cash
₹77.84 Cr
Total Debt
₹9.81 Cr
Debt to Equity
4.98%

Stock Information

52 Week Range
₹273.6 - ₹562.8
Beta
1.14
Shares Outstanding
₹2.65 Cr

Dividends & Splits

Forward Dividend Yield
3.68%
Trailing Dividend Yield
0.00%
Payout Ratio
55.56%

Jagsonpal Pharmaceuticals Limited

533.5

INR
+1.50(+0.28%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹1383.79 Cr
Enterprise Value
₹1168.54 Cr
P/E Ratio (TTM)
57.90
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
6.10

Financial Metrics

Gross Margin
64.71%
Operating Margin
18.67%
Return on Equity
13.26%
Revenue (TTM)
₹226.85 Cr+29.2%
EBITDA
₹40.66 Cr
EPS (TTM)
₹9.01+53.400000000000006%

Balance Sheet

Total Cash
₹77.84 Cr
Total Debt
₹9.81 Cr
Debt to Equity
4.98%

Stock Information

52 Week Range
₹273.6 - ₹562.8
Beta
1.14
Shares Outstanding
₹2.65 Cr

Dividends & Splits

Forward Dividend Yield
3.68%
Trailing Dividend Yield
0.00%
Payout Ratio
55.56%